U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07408934) titled 'A Pilot Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)' on Dec. 04, 2025.
Brief Summary: Schizophrenia is a serious psychiatric disorder characterized by delusions, hallucinations, negative symptoms and disorganized behaviour. Antipsychotic medication is the main treatment for schizophrenia, but many people do not respond to treatment, and most who do respond continue to have significant symptoms. Thus, there is a need for additional treatment strategies.
Cognitive behavioural therapy for psychosis (CBTp) was developed to reduce distress associated with psychotic symptoms and improve function...